These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23761863)
1. Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1. Gartel AL Front Oncol; 2013; 3():150. PubMed ID: 23761863 [No Abstract] [Full Text] [Related]
2. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. Bhat UG; Halasi M; Gartel AL PLoS One; 2009; 4(5):e5592. PubMed ID: 19440351 [TBL] [Abstract][Full Text] [Related]
4. FoxM1 is a general target for proteasome inhibitors. Bhat UG; Halasi M; Gartel AL PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316 [TBL] [Abstract][Full Text] [Related]
5. New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer. Pandit B; Gartel AL Prostate; 2010 Jun; 70(8):825-33. PubMed ID: 20058240 [TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitory activity of thiazole antibiotics. Pandit B; Bhat UG; Gartel AL Cancer Biol Ther; 2011 Jan; 11(1):43-7. PubMed ID: 21119308 [TBL] [Abstract][Full Text] [Related]
7. A new target for proteasome inhibitors: FoxM1. Gartel AL Expert Opin Investig Drugs; 2010 Feb; 19(2):235-42. PubMed ID: 20074015 [TBL] [Abstract][Full Text] [Related]
8. In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer. Chen Y; Ruben EA; Rajadas J; Teng NNH Bioorg Med Chem; 2015 Aug; 23(15):4576-4582. PubMed ID: 26164623 [TBL] [Abstract][Full Text] [Related]
14. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Hegde NS; Sanders DA; Rodriguez R; Balasubramanian S Nat Chem; 2011 Aug; 3(9):725-31. PubMed ID: 21860463 [TBL] [Abstract][Full Text] [Related]
15. Targeting FOXM1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer. Westhoff GL; Chen Y; Teng NNH Int J Gynecol Cancer; 2017 Oct; 27(8):1602-1609. PubMed ID: 28692634 [TBL] [Abstract][Full Text] [Related]
16. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Radhakrishnan SK; Bhat UG; Hughes DE; Wang IC; Costa RH; Gartel AL Cancer Res; 2006 Oct; 66(19):9731-5. PubMed ID: 17018632 [TBL] [Abstract][Full Text] [Related]
17. Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer. Westhoff GL; Chen Y; Teng NNH Int J Gynecol Cancer; 2017 Jun; 27(5):887-894. PubMed ID: 28498253 [TBL] [Abstract][Full Text] [Related]
18. Siomycin A Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells by Suppressing the Expression of FoxM1. Guo X; Liu A; Hua H; Lu H; Zhang D; Lin Y; Sun Q; Zhu X; Yan G; Zhao F Nat Prod Commun; 2015 Sep; 10(9):1603-6. PubMed ID: 26594769 [TBL] [Abstract][Full Text] [Related]
19. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371 [TBL] [Abstract][Full Text] [Related]
20. The Clinical and Experimental Research on the Treatment of Endometriosis with Thiostrepton. Jin P; Chen X; Yu G; Li Z; Zhang Q; Zhang JV Anticancer Agents Med Chem; 2019; 19(3):323-329. PubMed ID: 29308746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]